Expression of vascular endothelial growth factor and its receptors flt and KDR in ovarian carcinoma.
about
Inhibition of vascular endothelial growth factor expression in HEC1A endometrial cancer cells through interactions of estrogen receptor alpha and Sp3 proteinsSrc homology 2 (SH2) domain containing protein tyrosine phosphatase-1 (SHP-1) dephosphorylates VEGF Receptor-2 and attenuates endothelial DNA synthesis, but not migrationGADD45 proteins: central players in tumorigenesisVascular endothelial growth factor receptor-2-mediated mitogenesis is negatively regulated by vascular endothelial growth factor receptor-1 in tumor epithelial cellsVascular endothelial growth factor mediates intracrine survival in human breast carcinoma cells through internally expressed VEGFR1/FLT1Quercetin-4'-O-β-D-glucopyranoside (QODG) inhibits angiogenesis by suppressing VEGFR2-mediated signaling in zebrafish and endothelial cellsOvarian cancer cell line panel (OCCP): clinical importance of in vitro morphological subtypesUltrasound Molecular Imaging of Angiogenesis Using Vascular Endothelial Growth Factor-Conjugated Microbubbles.Activity of sorafenib in recurrent ovarian cancer and primary peritoneal carcinomatosis: a gynecologic oncology group trial.Immunolocalisation of the VEGF receptors FLT-1, KDR, and FLT-4 in diabetic retinopathy.Chronic cocaine induces HIF-VEGF pathway activation along with angiogenesis in the brain.Purinergic mechanisms in breast cancer support intravasation, extravasation and angiogenesis.Role of vascular endothelial growth factor inhibitors in the treatment of gynecologic malignancies.Angiogenesis in epithelian ovarian cancer.Combinatorial effect of non-steroidal anti-inflammatory drugs and NF-κB inhibitors in ovarian cancer therapy.DNA methylation regulates expression of VEGF-R2 (KDR) and VEGF-R3 (FLT4).Vascular endothelial growth factor receptor-1 activation mediates epithelial to mesenchymal transition in hepatocellular carcinoma cells.Expression of sorafenib targets in melanoma patients treated with carboplatin, paclitaxel and sorafenib.Pathological significance of vascular endothelial growth factor A isoform expression in human cancer.Double suicide genes driven by kinase domain insert containing receptor promoter selectively kill human lung cancer cellsSoluble flt-1 and the angiopoietins in the development and regulation of placental vasculature.Overexpression of tumor vascular endothelial growth factor A may portend an increased likelihood of progression in a phase II trial of bevacizumab and erlotinib in resistant ovarian cancerTargeted therapies in epithelial ovarian cancer: Molecular mechanisms of action.Immunization with synthetic VEGF peptides in ovarian cancerTherapies directed at vascular endothelial growth factor.Novel function for vascular endothelial growth factor receptor-1 on epidermal keratinocytes.VEGF blocking therapy in the treatment of cancer.Diverse mechanisms for activation of Wnt signalling in the ovarian tumour microenvironment.Identification of common mechanisms between endometriosis and ovarian cancer.Vascular endothelial growth factor in females of reproductive age.Expresson of vascular endothelial growth factor, its receptors (FLT-1, KDR) and TSP-1 related to microvessel density and patient outcome in vertical growth phase melanomas.Vascular endothelial growth factor-165 overexpression stimulates angiogenesis and induces cyst formation and macrophage infiltration in human ovarian cancer xenografts.Generation of a syngeneic mouse model to study the effects of vascular endothelial growth factor in ovarian carcinoma.What is the role of vascular endothelial growth factor-related molecules in tumor angiogenesis?Role of vascular endothelial growth factor in ovarian cancer: inhibition of ascites formation by immunoneutralizationRole of endothelin-1 in neovascularization of ovarian carcinomaMolecular determinants of ovarian cancer plasticity.ETS-1 protein regulates vascular endothelial growth factor-induced matrix metalloproteinase-9 and matrix metalloproteinase-13 expression in human ovarian carcinoma cell line SKOV-3.Significance of vascular endothelial growth factor in growth and peritoneal dissemination of ovarian cancer.Prognostic significance of vascular endothelial growth factor serum determination in women with ovarian cancer
P2860
Q22254113-53EF61E4-E54A-43C9-BB6E-957B1AE897B7Q24315888-ACED2FB4-15AA-4C40-B634-FD5DAF81CED1Q24608649-B022AF87-6E30-4C89-B01D-E9AA09D6CEA4Q28345678-33D7D298-F919-4A12-AAC8-C7F41BF3165EQ28469224-C8932ADB-29E3-4BB8-937F-E9F07687ECB6Q28480617-603ADC2B-F7EE-40B4-83AF-BFA0EFC47B17Q28543021-0A7FAE4B-2BAB-4F5E-A054-9F2CD04C9204Q30359568-CED69000-DF65-4E3E-8C36-D6461B61080CQ30429122-0E07D65E-471A-4EF4-8B3D-0098D7E709E1Q30750084-B444AA30-BC72-4895-B417-3F40BA1A0C0DQ33610969-FFBA224C-A47B-4B5A-99F7-9C9856D3A26DQ33770947-3099AE96-B71F-4DBB-9FF7-3CCB6455C08FQ33771212-C42D879C-8933-4D50-8C1C-B54884E79206Q33919078-0AB30D6C-66C0-402E-B3B8-E3A48BA76656Q34023344-EC514410-93D5-46AF-907C-93D439596BB1Q34129693-720B66D4-EAFB-4296-9698-535206431067Q34166351-35ABA6DB-A37C-4D82-AEF2-AD7FE9B27000Q34678882-2BFA43A5-0BCE-4F1E-A098-BF95B01ABFB8Q34722935-0C28ABA4-0974-4D19-93B8-CEC310499B7DQ34748791-0901DCC9-BBEA-4B83-9B0C-39FB788C32DEQ34774019-75223363-2419-4D07-AC70-35E0B807C780Q34781970-51501763-DEC8-4608-818E-21E75B5C96EBQ34878868-8CDAA330-4F0A-43AB-BBB2-D006CC2027E0Q34901858-10EF09A7-5047-41F4-9285-A9D4961DCA48Q35011885-4F40AF7D-07CA-4961-A85C-3CB14446556BQ35085430-BB386453-2CF3-4FE0-8299-78C3F81C95EFQ35093616-0E20C6E2-B78A-43CA-A804-5D288E19D3A1Q35098085-C45A44AD-66F6-4DF4-896B-6B4024FC4DC6Q35562421-C9D94923-74E8-43CE-9FA6-53FC862C73EBQ35678769-D98DF6D0-6D75-4666-B15D-35B47981512DQ35746653-27630256-8EB7-4C80-9389-6A142FA2CCE2Q35747351-25C8AE08-0C10-4CDF-88C5-FFE9DBCAADB2Q35748149-B350F5DA-7C5D-4E2D-BD75-C37D63D37457Q35753158-2DF05DDC-B3F1-47B2-9D6C-1D153E2DD346Q35753569-6DD89F0F-52ED-4B79-A76F-23C2E616CD9BQ35829525-67BDA3B7-DDB0-4F4A-AD3B-464D01DCE0A7Q35842085-94BB9893-7122-49D8-8389-C154576B61B2Q35922535-828D60F0-421A-42AB-91EC-9AC5019CAA6DQ35954103-C91535EA-E9AF-4B1D-9CFF-AF07F93A9301Q36077140-98821A88-0485-4D0F-A58F-56AC6CDDEA47
P2860
Expression of vascular endothelial growth factor and its receptors flt and KDR in ovarian carcinoma.
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
1995年论文
@zh
1995年论文
@zh-cn
name
Expression of vascular endothe ...... and KDR in ovarian carcinoma.
@en
Expression of vascular endothe ...... and KDR in ovarian carcinoma.
@nl
type
label
Expression of vascular endothe ...... and KDR in ovarian carcinoma.
@en
Expression of vascular endothe ...... and KDR in ovarian carcinoma.
@nl
prefLabel
Expression of vascular endothe ...... and KDR in ovarian carcinoma.
@en
Expression of vascular endothe ...... and KDR in ovarian carcinoma.
@nl
P2093
P4510
P356
P1476
Expression of vascular endothe ...... t and KDR in ovarian carcinoma
@en
P2093
C A Boocock
K A Wright
P J Barker
P R Twentyman
P304
P356
10.1093/JNCI/87.7.506
P407
P577
1995-04-01T00:00:00Z